Evidence map›Paper›PMID 28611187›Full record

Observational studyCirculation. Cardiovascular quality and outcomes2017

Comparing Outcomes of Coronary Artery Bypass Grafting Among Large Teaching and Urban Hospitals in China and the United States.

Zhe Zheng, Heng Zhang, Xin Yuan, Chenfei Rao, Yan Zhao, Yun Wang, Sharon-Lise Normand, Harlan M Krumholz, Shengshou Hu

Open access · hybridAbstract readComparative StudyObservational Study
In one paragraph

Observational study in Circulation. Cardiovascular quality and outcomes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Effectiveness of Saphenous Vein Y-Grafts in Patients Undergoing Off-Pump Complete Myocardial Revascularization.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zhe ZhengFrom the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.).
Heng ZhangFrom the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.).
Xin YuanFrom the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.).
Chenfei RaoFrom the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.).
Yan ZhaoFrom the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.).
Yun WangFrom the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.).
Sharon-Lise NormandFrom the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.).
Harlan M KrumholzFrom the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.).
Shengshou HuFrom the National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease (Z.Z., H.Z., X.Y., C.R., Y.Z., S.H.), and Department of Cardiovascular Surgery (Z.Z., H.Z., X.Y., C.R., S.H.), Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Health Care Policy, Harvard Medical School and the Department of Biostatistics, Boston, MA (S.-L.N.); Harvard T.H. Chan School of Public Health, Boston, MA (Y.W., S.-L.N.); Center for Outcomes Research and Evaluation, Yale New Haven Health, CT (Y.W., H.M.K.); Section of Cardiovascular Medicine, Department of Internal Medicine (H.M.K.), and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (H.M.K.), Yale School of Medicine, New Haven, CT; and Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (H.M.K.). zhengzhe@fuwai.com shengshouhu@yahoo.com.
Yale New Haven Health System · USHarvard University · USRobert Wood Johnson Foundation · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

backgroundCoronary artery disease is prevalent in China, with concomitant increases in the volume of coronary artery bypass grafting (CABG). The present study aims to compare CABG-related outcomes between China and the United States among large teaching and urban hospitals. METHODS AND

resultsObservational analysis of patients aged ≥18 years, discharged from acute-care, large teaching and urban hospitals in China and the United States after hospitalization for an isolated CABG surgery. Data were obtained from the Chinese Cardiac Surgery Registry in China and the National Inpatient Sample in the United States. Analysis was stratified by 2 periods: 2007, 2008, and 2010; and 2011 to 2013 periods. The primary outcome was in-hospital mortality, and the secondary outcome was length of stay. The sample included 51 408 patients: 32 040 from 77 hospitals in the China-CABG group and 19 368 from 303 hospitals in the US-CABG group. In the 2007 to 2008, 2010 period and for all-age and aged ≥65 years, the China-CABG group had higher mortality than the US-CABG group (1.91% versus 1.58%,

conclusionsIn 2011 to 2013, there was no significant difference in in-hospital mortality among patients who underwent an isolated CABG surgery in large teaching and urban hospitals in China and the United States. The longer length of stay in China may represent an opportunity for improvement.

Indexed as

Coronary Artery BypassHospitals, TeachingHospitals, UrbanProcess Assessment, Health CareAdolescentAdultAgedChinaCoronary Artery DiseaseFemaleHealthcare DisparitiesHospital Bed CapacityHospital MortalityHospitals, High-VolumeHumansLength of Staycomorbiditycoronary artery bypass graftingcoronary artery diseasehospital mortalitylength of stay

Identifiers

PMID28611187
PMCPMC5482563
OpenAlexW2626566926

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.